Effects of Transfusion of Older Stored Red Cells
NCT01534676 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3
Last updated 2016-10-05
Summary
The purpose of this study is to determine the effects of transfusion of fresh and stored blood on patients.
The investigators hope to test:
* whether a similar effect (older stored blood is associated with worse outcomes) is seen in chronically transfused patients with hemoglobinopathies. This patient population will also allow the investigators to test whether iron- chelation therapy is beneficial in this setting.
* whether washing or cryopreserving the red blood cells has any effect on this outcome.
These findings may explain the immunomodulatory effects of older stored blood in patients and will help us develop safer transfusion products for patients.
Conditions
Interventions
- PROCEDURE
-
Transfusion
A routine medical procedure to transfuse packed red blood cells.
- BIOLOGICAL
-
Blood
Processing of RBC for transfusion include the following: * Fresh * Stored * Washed * Frozen (Cryopreserved)
- PROCEDURE
-
Chelation therapy
(non-experimental) A medical procedure that involves the administration of chelating agents to remove heavy metals from the body.
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH - lead OTHER
Principal Investigators
-
Steven Spitalnik, MD · Columbia University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Year
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-02-29
- Primary Completion
- 2013-03-31
- Completion
- 2013-03-31
Countries
- United States
Study Locations
More Related Trials
-
Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients
NCT00303329 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Blood Transfusion on Endothelial Function
NCT02161042 ·Status: COMPLETED
-
Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor (GCSF) Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients With Betathalassemia Major
NCT00658385 ·Status: COMPLETED ·Phase: NA
-
Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients
NCT01398644 ·Status: UNKNOWN ·Phase: PHASE3
-
Haploidentical Hematopoietic Stem Cell Transplantation
NCT02165007 ·Status: COMPLETED ·Phase: PHASE1
-
Allograft for Sickle Cell Disease and Thalassemia
NCT02038478 ·Status: WITHDRAWN ·Phase: PHASE2
-
Sickle Cell Disease: A Retrospective Chart Review
NCT01441375 ·Status: COMPLETED
-
Invasive Infections in Children With Hemoglobinopathies
NCT00456443 ·Status: COMPLETED
-
Iron Replacement in Blood Donors
NCT00327067 ·Status: COMPLETED
-
HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity
NCT02435901 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Allogeneic Genoidentical Stem Cell Transplantation in Children With Sickle-cell Anemia and Cerebral Vasculopathy
NCT01340404 ·Status: COMPLETED ·Phase: NA
-
The Impact of Red Packed Cells Transfusion on the Main Biological Markers to Determine the Etiology of Anemias
NCT01409967 ·Status: COMPLETED
-
Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study
NCT00661804 ·Status: COMPLETED
-
Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
NCT01239901 ·Status: COMPLETED
-
5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia
NCT00005934 ·Status: COMPLETED ·Phase: PHASE2
-
The Impact of Oxidative Stress on Erythrocyte Biology
NCT04028700 ·Status: TERMINATED ·Phase: PHASE2
-
Multi-Center Study of Iron Overload: Pilot Study
NCT01114776 ·Status: COMPLETED
-
Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions
NCT00872833 ·Status: COMPLETED
-
A Long-term Follow-up Study in Participants Who Received CS-101
NCT06479616 ·Status: RECRUITING ·Phase: NA
-
RHD Genotype Matched Red Cells for Anti-D
NCT04156906 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
RH Genotype Matched RBC Transfusions
NCT04156893 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Unrelated Umbilical Cord Blood Following HLA-haploidentical Hematopoietic Stem Cell Transplantation in Patients With β-thalassemia Major
NCT02126046 ·Status: UNKNOWN ·Phase: NA
-
Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy
NCT00202436 ·Status: COMPLETED ·Phase: PHASE3
-
Iron Interventions and Non-transferrin-bound Iron (NTBI) in Women
NCT01404533 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Efficacy and Safety of S303 Treated Red Blood Cells (RBCs)in Subjects With Thalassemia Major Requiring Chronic RBC Transfusion
NCT01740531 ·Status: COMPLETED ·Phase: PHASE3